Japanese scientists develop a new device for metronomic photodynamic therapy to facilitate a minimally-invasive and effective cancer treatment in delicate organs
Scientists from Waseda University, the National Defense Medical College, and the Japan Science and Technology Agency developed a new bioadhesive, wirelessly-powered light-emitting device which could better treat cancers in delicate organs.
Conventional photodynamic therapy induces cancer cell death by using photosensitizing agents, which localize in tumors and activate with exposure to a specific wavelength of light. In recent years, low-dose and long-term photodynamic therapy (metronomic photodynamic therapy, mPDT) has shown promise in treating cancers in internal organs. The problem with mPDT is, however, is that because the light intensity is extremely low (1/1000 of the conventional method), the antitumor effect cannot be obtained if the light source shifts even slightly away from the tumor, making the illumination insufficient.
“To address this issue, we have developed a wirelessly-powered optoelectronic device that stably fixes itself onto the inner surface of an animal tissue like a sticker with bioadhesive and elastic nanosheets, enabling a continuous, local light delivery to the tumor,” says Toshinori Fujie, associate professor of biomedical engineering at Waseda University. The nanosheets are modified with the mussel adhesive protein-inspired polymer polydopamine, which can stabilize the device onto a wet animal tissue for more than 2 weeks without surgical suturing or medical glue. The light-emitting diode chips in the device are wirelessly powered by near-field-communication technology.
To test its effectiveness, tumor-bearing mice implanted with the device were injected with a photosensitizing agent (photofrin) and exposed to red and green light, approximately 1,000-fold intensity lower than the conventional PDT approaches, for 10 consecutive days. The experiment showed that the tumor growth was significantly reduced overall. Especially under green light, the tumor in some mice was completely eradicated.
Associate Professor Fujie points out, “This device may facilitate treatment for hard-to-detect microtumors and deeply located lesions that are hard to reach with standard phototherapy, without having to worry about the risk of damaging healthy tissues by overheating. Furthermore, because the device does not require surgical suturing, it is suitable for treating cancer near major nerves and blood vessels, as well as for organs that are fragile, that change their shape, or that actively move, such as the brain, liver, and pancreas.”
If clinically applied, the device could be beneficial for cancer patients who seek minimally invasive treatment, helping them live longer and improve their quality of life.
The Latest on: Photodynamic therapy
via Google News
The Latest on: Photodynamic therapy
- New research focuses on endo pain relief issues on April 12, 2019 at 12:21 am
The presentations included research on the use of photodynamic therapy, persistent pain after root end surgery, and the link between depression and postoperative pain. In the first poster presentation ... […]
- Photodynamic therapy guidelines for the management of oral leucoplakia on April 10, 2019 at 3:24 pm
With recent developments in photosensitizers and light delivery systems, topical 5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) has become the fourth alternative therapeutic approach in ... […]
- New patient treatment, phase 2 initiated on April 10, 2019 at 2:13 am
The treatment was performed with SpectraCure's photodynamic therapy (PDT) method. The procedure went as expected and the patient is doing well. "It is gratifying that we are now officially entering ... […]
- Low dose photodynamic therapy shows promise in the treatment of cancerous tumors on April 5, 2019 at 10:57 am
A new study reveals the mechanisms whereby low dose photodynamic therapy affects the microstructure of vessels. Using co-cultures of pericytes and endothelial cells in vitro, the authors show that ... […]
- SpectraCure files for a new patent on April 5, 2019 at 5:53 am
The IDOSE technique is at the heart of the company's method of treating prostate cancer with photodynamic therapy (PDT). In short, the technique implies that the prostate tissue is monitored during ... […]
- Silver Cross was 1st to Offer Photodynamic Therapy for Cancer of the Esophagus; Joliet Man Shows No Sign of Cancer after Procedure on April 3, 2019 at 3:18 pm
One morning last May, Joliet resident Salvatore Fisher had the startling and terrifying realization that he had lost his ability to swallow everything - even water. When home remedies failed, he ... […]
- Theralase’s Phase IB Clinical Study to be Presented at the 17(th) International Photodynamic Association World Congress on March 26, 2019 at 4:13 am
IPA has been bringing together researchers and clinicians in all fields of PhotoDynamic Therapy ("PDT") and PhotoDiagnosis ("PD") since 1986. Every two years, the IPA organizes a conference to foster ... […]
- Biofrontera Reports Positive Phase III Results with Ameluz® for photodynamic therapy of actinic keratoses on the extremities and trunk/neck on March 20, 2019 at 9:56 am
Leverkusen, Germany, March 20, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today received positive preliminary ... […]
- Did a Mexican Researcher Develop a Potential Treatment for HPV? on March 18, 2019 at 9:38 am
Ramón Gallegos’ work, which she has carried out for 20 years, involves the use of photodynamic therapy, in which a drug (referred to as a “photosensitizer”) is injected into the HPV patient’s ... […]
via Bing News